David H Barker1, Alexandra L Quittner2. 1. Department of Psychiatry, Rhode Island Hospital, Providence, Rhode Island; Department of Psychiatry and Human Behavior, Warren Alpert Medical School, Brown University, Providence, Rhode Island; and david_barker@brown.edu. 2. Department of Psychology, University of Miami, Miami, Florida.
Abstract
BACKGROUND: Treatment adherence in cystic fibrosis (CF) is often poor, however, less is known about adherence to pancreatic enzymes, a critical component of the CF treatment regimen. Parent caregivers often report elevations in depression, and parental depression may adversely affect children's adherence. METHODS: This prospective study evaluated adherence to pancreatic enzymes in 83 patients (1-13 years) . Adherence was measured across 3 months with electronic pill-caps . Weight was measured at baseline and a 3-month follow-up. Parental depressive symptoms were evaluated by using the Center for Epidemiologic Studies Depression Scale (CES-D). RESULTS: Adherence to pancreatic enzymes was 49.4% ± 3.4%. Adherence was higher at school (94.4% ± 6.1%) than at home (42.3% ± 3.1%), and higher for toddlers (50.6% ± 5.2%) than for school-aged children (37.5% ± 3.7%). Parents reported high rates of depressive symptoms (30% in the clinical range, 18% with moderate symptoms). Children of parents with symptoms of depression versus those without were less adherent (34.8% ± 4.5% vs 48.5% ± 4.1%), and adherence to enzymes was significantly related to 3-month weight outcomes. Average gain in weight z scores across 3 months was 0.5 ± 0.2for children who were >50% adherent and -0.1 ± 6.1for children who were <33% adherent. Parental depression had a signifcant, indirect effect on weight via adherence (-0.005 ± 0.003 gain in weight z score per CES-D unit ). CONCLUSIONS: High rates of parental depressive symptoms, coupled with its negative effects on adherence, suggest that measuring and treating parental depression may improve children's adherence to therapy.
BACKGROUND: Treatment adherence in cystic fibrosis (CF) is often poor, however, less is known about adherence to pancreatic enzymes, a critical component of the CF treatment regimen. Parent caregivers often report elevations in depression, and parental depression may adversely affect children's adherence. METHODS: This prospective study evaluated adherence to pancreatic enzymes in 83 patients (1-13 years) . Adherence was measured across 3 months with electronic pill-caps . Weight was measured at baseline and a 3-month follow-up. Parental depressive symptoms were evaluated by using the Center for Epidemiologic Studies Depression Scale (CES-D). RESULTS: Adherence to pancreatic enzymes was 49.4% ± 3.4%. Adherence was higher at school (94.4% ± 6.1%) than at home (42.3% ± 3.1%), and higher for toddlers (50.6% ± 5.2%) than for school-aged children (37.5% ± 3.7%). Parents reported high rates of depressive symptoms (30% in the clinical range, 18% with moderate symptoms). Children of parents with symptoms of depression versus those without were less adherent (34.8% ± 4.5% vs 48.5% ± 4.1%), and adherence to enzymes was significantly related to 3-month weight outcomes. Average gain in weight z scores across 3 months was 0.5 ± 0.2for children who were >50% adherent and -0.1 ± 6.1for children who were <33% adherent. Parental depression had a signifcant, indirect effect on weight via adherence (-0.005 ± 0.003 gain in weight z score per CES-D unit ). CONCLUSIONS: High rates of parental depressive symptoms, coupled with its negative effects on adherence, suggest that measuring and treating parental depression may improve children's adherence to therapy.
Authors: Daniel H Grossoehme; Rhonda D Szczesniak; LaCrecia L Britton; Christopher M Siracusa; Alexandra L Quittner; Barbara A Chini; Sophia M Dimitriou; Michael Seid Journal: Ann Am Thorac Soc Date: 2015-06
Authors: Alexandra L Quittner; David H Barker; Carolyn Snell; Mary E Grimley; Kristen Marciel; Ivette Cruz Journal: Curr Opin Pulm Med Date: 2008-11 Impact factor: 3.155
Authors: Robin S Everhart; Barbara H Fiese; Joshua M Smyth; Adrienne Borschuk; Ran D Anbar Journal: Pediatr Allergy Immunol Pulmonol Date: 2014-06-01 Impact factor: 1.349
Authors: Scott W Powers; Lori J Stark; Leigh A Chamberlin; Stephanie S Filigno; Stephanie M Sullivan; Kathleen L Lemanek; Jennifer L Butcher; Kimberly A Driscoll; Cori L Daines; Alan S Brody; Teresa Schindler; Michael W Konstan; Karen S McCoy; Samya Z Nasr; Robert G Castile; James D Acton; Jamie L Wooldridge; Roberta A Ksenich; Rhonda D Szczesniak; Joseph R Rausch; Virginia A Stallings; Babette S Zemel; John P Clancy Journal: JAMA Pediatr Date: 2015-05-04 Impact factor: 16.193
Authors: Reham Almardini; Esra' O Taybeh; Mervat M Alsous; Ahmed F Hawwa; Karl McKeever; Rob Horne; James C McElnay Journal: Br J Clin Pharmacol Date: 2019-05-11 Impact factor: 4.335